Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
67 /100
COMPONENT-LIMITED
Score updated Oct 28, 2026

ENTX — Entera Bio Ltd. Dilution Risk Tracker

Track ENTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track ENTX — Get alerts when the score changes →

As of October 28, 2026, Entera Bio Ltd. (ENTX) has a DilutionWatch DilutionScore of 67/100, rated HIGH dilution risk. This is a component-limited score because one or more material inputs are unavailable or not applicable. Entera Bio Ltd. has a market capitalization of $529.81M, 173.14M shares outstanding, 27 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
80
💰 Cash Runway
40
📊Float Risk—
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 5%
📉 Score Deterioration model 10%
• Score in HIGH risk zone (67/100)
🔔 Track ENTX — Get forecast alerts →

Market Data

Market Cap$529.81M
Shares Outstanding173.14M
Float31.37M
Cash$11.31M
DebtN/A
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore67/100DilutionWatch score record
Shares Outstanding173.14MVerified float table or market cache
Public Float31.37MVerified float table or market cache
Market Cap$529.81MMarket data cache
Cash Runway17.0 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding WarrantsNone in current score inputsSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 6.

Recent SEC source mix: 3 1, 4 3, EFFECT 1, XBRL 1.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

ENTX SEC Filing Activity — Last 12 Months

Shares outstanding reported by ENTX on the cover page of its latest 10-K/10-Q: 173.14M as of August 03, 2026.

DilutionWatch recorded no shelf, registration or prospectus documents for ENTX in the last 12 months. Full filing list on SEC EDGAR →

FormWhat it isFilingsMost recent
8-Kcurrent report (material event)4Oct 27, 2026
10-Qquarterly report1Aug 07, 2026
DEF 14Aproxy statement1Oct 14, 2026
SC 13Dactivist / >5% holder filing1Aug 04, 2026
SC 13Gpassive >5% holder filing3Aug 04, 2026
3initial insider ownership8Sep 23, 2026

Institutional Holdings

QoQ: ↓ 12.8% shares (2026Q1 vs prior)
27 institutional holders · 8.04M shares
#1 Knoll Capital Management, LLC 5.88M shares
#2 RENAISSANCE TECHNOLOGIES LLC 473.4K shares
#3 Seven Fleet Capital Management LP 340.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest5.55M
Days to Cover7.2
% of Float17.7%
FINRA data as of Oct 15, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2026-03-27
EFFECT EFFECT 2026-08-28
3 FORM3 2026-08-21
4 INSIDER TRANSACTION 2026-08-07
4 INSIDER TRANSACTION 2026-08-07
Full SEC filing analysis available with free account →

Recent News

Factual ENTX Dilution Snapshot

Entera Bio Ltd. (ENTX) has a DilutionScore of 67/100, rated High dilution risk. Score date: October 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

ENTX's DilutionScore is currently 67/100 (High risk), with 4 score changes tracked over 89 days. The score improved from 62/100 (High risk).

Period Score Risk Level Duration
Oct 02 – Oct 28, 202667/100HIGH27 days
Aug 31 – Oct 01, 202662/100HIGH32 days
Aug 22 – Aug 30, 202649/100MEDIUM9 days
Aug 14 – Aug 21, 202644/100MEDIUM7 days
Jul 31 – Aug 13, 202648/100MEDIUM14 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Track ENTX Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment ENTX files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking ENTX — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,567+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations

Score Coverage Note

More Research for ENTX
ENTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.